NHS
Get informed when a big investor buys or sells
+ FollowOvervalued by 48.6% based on the discounted cash flow analysis.
| Market cap | $200.87 Million |
|---|---|
| Enterprise Value | $302.05 Million |
| Dividend Yield | $1.09 (16.97%) |
| Earnings per Share | $0.66 |
| Beta | 0.76 |
| Outstanding Shares | 30,746,750 |
| P/E Ratio | 9.73 |
|---|---|
| PEG | 85.86 |
| Price to Sales | 6.34 |
| Price to Book Ratio | 0.91 |
| Enterprise Value to Revenue | 6.75 |
| Enterprise Value to EBIT | 4.94 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | 0.33 |
| Debt to Equity | 0.43 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 21.89%▲ 8.83% |
|---|---|
| Total Invested | $43.23M▲ 44.68% |
| Investors Holding | 54▲ 11.00% |
No data
Neuberger Berman High Yield Strategies Fund Inc. is a diversified, closed-end management investment company investing in the high yield debt securities market. The Fund utilizes leverage through the issuance of privately placed notes and preferred stock.